HIV coreceptor usage and drug treatment

Area of Science:

• Virology
• Immunology
• Mathematical Biology

Background:

• Human immunodeficiency virus (HIV) utilizes CD4 receptors and coreceptors like CCR5 and CXCR4 for cell entry.
• Antiretroviral therapies can target specific HIV phenotypes based on their coreceptor tropism.
• Understanding HIV coreceptor usage is crucial for developing effective treatment strategies.

Purpose of the Study:

• To analyze mathematical models of HIV coreceptor usage in vivo.
• To investigate how coreceptor-specific antiretroviral agents alter selection pressures on CCR5- and CXCR4-using HIV variants.
• To evaluate the impact of these agents on the coexistence of different HIV phenotypes.

Main Methods:

• Development and analysis of mathematical models simulating HIV-host cell interactions.
• Modeling the dynamics of HIV variants with differing coreceptor tropisms (CCR5-using and CXCR4-using).
• Simulation of treatment scenarios using coreceptor-specific antiretroviral agents.

Main Results:

• CXCR4 inhibitors were found to increase selection pressure favoring CCR5-using HIV variants.
• CCR5 inhibitors were found to increase selection pressure against CCR5-using HIV variants.
• The study predicts that CXCR4 inhibitors may lead to the coexistence of both CCR5- and CXCR4-using HIV, while CCR5 inhibitors select against this coexistence.

Conclusions:

• Coreceptor inhibitor therapy can have complex and sometimes counterintuitive effects on HIV tropism selection.
• CXCR4 inhibitors may inadvertently promote the emergence of CCR5-tropic HIV, potentially complicating treatment.
• CCR5 inhibitors appear to more effectively suppress CCR5-tropic HIV, reducing the likelihood of mixed-tropism infections.